Clinical Trial Update: Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania [Phase 4]

View source ↗

Summary

A Phase 4 study assessing adjunctive lithium for psychotic mania in Bipolar I Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: Northwell Health | Conditions: Bipolar I Disorder | Phase 4 | Status: WITHDRAWN